UK markets open in 36 minutes
NIKKEI 225
38,274.05 -131.61 (-0.34%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.14 -0.79 (-0.96%) GOLD FUTURES
2,298.20 -4.70 (-0.20%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
47,955.19 -2,835.30 (-5.58%)
Oncternal Therapeutics, Inc. (GTU.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 09:00AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 23.44M |
| Enterprise value | -8.26M |
| Trailing P/E | 2.15 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 0.56 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 0.20 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.37 |
| 52-week change 3 | -9.52% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 11.8000 |
| 52-week low 3 | 0.0000 |
| 50-day moving average 3 | 5.3200 |
| 200-day moving average 3 | 5.5424 |
Share statistics
| Avg vol (3-month) 3 | N/A |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 2.96M |
| Implied shares outstanding 6 | 4.65M |
| Float 8 | 2.68M |
| % held by insiders 1 | 9.23% |
| % held by institutions 1 | 15.24% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 08 Jan 2024 |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -3,244.44% |
Management effectiveness
| Return on assets (ttm) | -49.48% |
| Return on equity (ttm) | -86.75% |
Income statement
| Revenue (ttm) | 785k |
| Revenue per share (ttm) | 0.27 |
| Quarterly revenue growth (yoy) | 73.70% |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -39.48M |
| Diluted EPS (ttm) | N/A |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 34.26M |
| Total cash per share (mrq) | 11.57 |
| Total debt (mrq) | 318k |
| Total debt/equity (mrq) | 1.06% |
| Current ratio (mrq) | 6.94 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | -32.16M |
| Levered free cash flow (ttm) | -19.38M |
© 2024 Yahoo. All rights reserved.